Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on June 3, 2022. The filing addresses a change in the composition of the Board of Directors and corporate leadership roles.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Leadership Transition: Scott G. Stephen assumed the position of Chairman of the Board of Directors effective June 3, 2022.
- Role Continuity: Martin A. Sumichrast vacated the Chairman position but remains on the Board of Directors and continues to serve as Chief Executive Officer.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document is limited to the announcement of the board appointment.
Investor Verification Checklist
- Verify the effective date of Scott G. Stephen's appointment as Chairman.
- Confirm Martin A. Sumichrast's continued tenure as CEO and Board member.
- Review the Company's most recent 10-K or 10-Q for financial metrics not included in this 8-K.